Yokogawa Concludes Agreement with Olympus America
OREANDA-NEWS. August 22, 2012. Yokogawa Electric Corporation is pleased to announce the conclusion of an agreement whereby the
By cooperating in sales with Olympus
The CellVoyager CV1000 can observe the biological changes in live cells for a long time without significant cell damages. At the core of this compact, all-in-one benchtop system are fully integrated components such as a CSU series spinning-disk confocal scanner unit, laser light sources, a scientific grade high-performance camera such as EMCCD, a precise X-Y stage, and an incubator capable of maintaining a fixed temperature, humidity, and CO2 level. This all-in-one confocal microscopy solution simplifies the task of observing live cells and eliminates the need to assemble such systems from separately purchased components. Since going on sale in January 2010, the CellVoyager CV1000 has been a global success.
Through this cooperative agreement, Yokogawa will benefit from Olympus America's name recognition and well established service network in North America, while Olympus America expects to expand its product line-up to strengthen its coverage of drug discovery research market. Both parties expect mutually beneficial business through the sales of CellVoyager CV1000 systems in the all-important North American biomedical research market.
Комментарии